Biosynergy is the future of medicine. It is a neologism that I have coined to describe the next paradigm shift in medical possibilities. Biosynergy will be the next revolution for mankind, and it will be even greater than all previous transformative technological innovations (except for the invention of light).
Biosynergy is fully harnessing beneficial properties of living organisms and customizing them to human health needs, at little cost to the human body, to cure diseases, regenerate organs, and restore functions. To achieve biosynergy we will rely on the progress made in genetic analysis and engineering. Examples of biosynergy include the use of viruses, instead of antibiotics, to fight infections more effectively and with fewer side effects. Biosynergy will enable us to create animals for organ harvesting, and eventually create spare kidneys, lungs, hips and livers, at will, and cost effectively. Damaged organs, will be fully restored with little trauma to the patient. Cancers will be easily cured. Stem cell transplants will be used to cure a myriad of genetic diseases. Biosynergy is also the use of animal senses for medical diagnoses with higher degrees of statistical accuracy than any known laboratory method.
How is biosynergy different from conventional medicine? To illustrate the change in paradigm I will need to highlight some of the greatest medical achievements of the past centuries. While medicine is an ancient craft, it only became beneficial to mankind in the past 150 years. Before, doctors’ errors killed as much as their salutary interventions. Dr. Ignaz Semmelweis intuition and Dr. Louis Pasteur’s discovery of disease transmission through germs, laid the ground for Dr. Alexander Fleming’s synthesis of Penicillin. Penicillin, better sanitation, and the progress of pharmaceutical research led to significant improvements in life expectancy. Another development was the improvement of surgery. A positive by-product of two world wars was the improvement in surgical methods which allowed physicians to repair an increasing number of organs and replace some of them with artificial prostheses. While all of these contributions enabled millions to live fuller lives, they conform to one paradigm.
Contemporary medicine facilitates the healing process, or uses drugs to kill disease causing pathogens in an indiscriminate manner. An orthopedist can intervene to ensure that a fracture heals properly, but a 60 year old person will take a much longer time to heal than a teenager. An adult will heal less well than an infant. An oncologist, or an infectious disease specialist, can prescribe antibiotics or chemotherapeutic agents that kill the bad bacteria and the cancerous cells, and inflict significant, often irremediable damage to good bacteria and healthy cells. Collateral damage is the cost of contemporary medicine.
Current medical interventions only enhance the body’s regenerative capacities in its healing process. The problem is that our regenerative potential declines with age, and we lack the capacity to fully restore damaged body structures. In contrast to conventional methods, biosynergic medications will be able to replenish the bodies healing potential altogether with little or no side effects. Biosynergic diagnostics will be made by examining an individual’s idiosyncratic genetic and biochemical make-up. Cancer, genetic diseases, will become what sepsis was a hundred years ago.
The good news is that research to leverage biological properties and fully customize them to human needs is already underway. The less enthusiastic news, is that it will take time for these ideas to mature, and they will require solutions to, as of yet, undefined problems; soliciting the talents of the greatest scientific minds. The microscope revolutionized biology, mathematics and statistical analyses methods will transform biosynergy. Over the next few months, I will share with you compelling articles on gene therapy, diagnostics, and other medical innovations that exemplify biosynergy as a paradigm improvement over medicine as we know it.